Planned 10,321-share Verastem (NASDAQ: VSTM) sale disclosed in filing
Rhea-AI Filing Summary
Verastem, Inc. insider Daniel Paterson has filed a Form 144 to sell 10,321 shares of Verastem common stock. The planned sale has an aggregate market value of $73,851.00 based on the figures provided, with the shares to be sold through Shareworks by Morgan Stanley on the NASDAQ, with an approximate sale date of 01/12/2026. Verastem had 66,776,006 common shares outstanding according to the notice.
The 10,321 shares proposed for sale were acquired on 01/10/2025 through the vesting of a restricted stock unit award from Verastem, with the same date listed as the payment date and the consideration described as N/A. The filing also lists multiple prior sales of Verastem securities by Daniel Paterson over the past three months, including 3,299 shares sold on 11/03/2025 for $32,146.00 and 2,000 shares sold on 12/11/2025 for $20,000.00.
Positive
- None.
Negative
- None.
FAQ
What does Verastem (VSTM)'s latest Form 144 filing disclose?
The Form 144 discloses that Daniel Paterson plans to sell 10,321 shares of Verastem, Inc. common stock, with an aggregate market value of $73,851.00, on the NASDAQ through Shareworks by Morgan Stanley.
What prior Verastem (VSTM) stock sales by Daniel Paterson are disclosed?
The filing lists several past three-month sales by Daniel Paterson, including 3,299 Verastem securities sold on 11/03/2025 for $32,146.00 and 2,000 sold on 12/11/2025 for $20,000.00, among other transactions.